Thoratec Set To Begin U.S. Trial Of Catheter Heart Pump To Assist PCI
This article was originally published in The Gray Sheet
Executive Summary
FDA has conditionally approved a 425-patient trial, called SHIELD II, comparing Thoratec's HeartMate PHP to Abiomed's Impella 2.5. The company expects the study to begin in the third quarter.